Type 28 spinocerebellar ataxia

We present a case of rare autosomal dominant spinocerebellar ataxia type 28 caused by a heterozygous mutation of the <i>AFG3L2</i> gene (SCA 28, SCA-AFG3L2, OMIM: 610246). The clinical presentation included a combination of visual and oculomotor disorders, extrapyramidal syndrome, epilepsy, and cerebellar ataxia. Female proband, 21 years old, 2 years of observation of the patient. Severe myopia has been reported since childhood. The disease manifested at the age of 14 with hand tremor and oculomotor disorders. Symptoms progressed over 5 years with an increase in oculomotor disorders, tremor, hypokinesia, cervical dystonia, left hand dystonia, elements of cerebellar ataxia, and the onset of epilepsy. Her parents were divorced; no data on the father was available; the family history was not reported until the relationship was restored. The proband's father and half-sister have similar symptoms, according to the proband (not medically confirmed by the authors). The patient was followed up for a long time with a diagnosis of a functional disorder of the nervous system. Type 28 spinocerebellar ataxia was diagnosed at the age of 19 years. Complete genome sequencing was performed; a heterozygous mutation c.838C >T (p.Arg280Trp) in the AFG3L2 gene was detected, and the mutation was confirmed using Sanger method. Direct Sanger sequencing was performed for the proband's father, and a similar mutation in the heterozygous state was confirmed. The proband's healthy mother had no such mutation. Segregation of these mutations in the family by the autosomal dominant type was found. The patient received levodopa 1250 mg/day, lamotrigine 400 mg/day, lacosamide 200 mg/day, as well as botulinum therapy for the muscles of the neck and left hand. Tremor and hypokinesia responded to levodopa. Sporadic epileptic seizures persist. The patient is socialized and studies at a higher educational institution.

Authors

Institutions

Publication Details

Journal
S S Korsakov Journal of Neurology and Psychiatry
Published
2025-11-20
DOI
https://doi.org/10.17116/jnevro202512511261
Primary Topic
Genetic Neurodegenerative Diseases
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Type 28 spinocerebellar ataxia

И. В. Литвиненко, И. В. Красаков, L.A. Khublarova
S S Korsakov Journal of Neurology and Psychiatry
Genetic Neurodegenerative Diseases
article

Type 28 spinocerebellar ataxia

И. В. Литвиненко, И. В. Красаков, L.A. Khublarova
article en

Abstract

We present a case of rare autosomal dominant spinocerebellar ataxia type 28 caused by a heterozygous mutation of the <i>AFG3L2</i> gene (SCA 28, SCA-AFG3L2, OMIM: 610246). The clinical presentation included a combination of visual and oculomotor disorders, extrapyramidal syndrome, epilepsy, and cerebellar ataxia. Female proband, 21 years old, 2 years of observation of the patient. Severe myopia has been reported since childhood. The disease manifested at the age of 14 with hand tremor and oculomotor disorders. Symptoms progressed over 5 years with an increase in oculomotor disorders, tremor, hypokinesia, cervical dystonia, left hand dystonia, elements of cerebellar ataxia, and the onset of epilepsy. Her parents were divorced; no data on the father was available; the family history was not reported until the relationship was restored. The proband's father and half-sister have similar symptoms, according to the proband (not medically confirmed by the authors). The patient was followed up for a long time with a diagnosis of a functional disorder of the nervous system. Type 28 spinocerebellar ataxia was diagnosed at the age of 19 years. Complete genome sequencing was performed; a heterozygous mutation c.838C >T (p.Arg280Trp) in the AFG3L2 gene was detected, and the mutation was confirmed using Sanger method. Direct Sanger sequencing was performed for the proband's father, and a similar mutation in the heterozygous state was confirmed. The proband's healthy mother had no such mutation. Segregation of these mutations in the family by the autosomal dominant type was found. The patient received levodopa 1250 mg/day, lamotrigine 400 mg/day, lacosamide 200 mg/day, as well as botulinum therapy for the muscles of the neck and left hand. Tremor and hypokinesia responded to levodopa. Sporadic epileptic seizures persist. The patient is socialized and studies at a higher educational institution.

S S Korsakov Journal of Neurology and PsychiatryVol. 125(11)
S. M. Kirov Military Medical Academy (RU), Nikiforov Russian Center of Emergency and Radiation Medicine (RU)
Openalex Percentile: Top 62%
Genetic Neurodegenerative Diseases
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.